CHLORTHALIDONE
Generic: CHLORTHALIDONE
TAGI PharmaManufacturer
ORALRoute
CHLORTHALIDONEActive Substance
2022-02-24Original Approval
CHLORTHALIDONE is FDA application ANDA212878, sponsored by PHARMOBEDIENT. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-02-07
Chlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100 Orthodox St. Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant o
Class II2025-05-09
Chlorthalidone Tablets, USP, 25 mg, 50 Tablets (5x10) Unit Dose cards per carton, Rx only, Manufactured for: AvKARE, PulFailed Dissolution Specifications
Class II2026-06-05
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare LimitFailed Dissolution Specifications
Class II2026-09-03
Chlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia Healthcare Limited. NDCFailed Dissolution Specifications
Class II2022-01-26
CHLORTHALIDONE Tablets, USP, 25MG, 1000 Tablets, Rx only, Manufactured by: Appco Pharma LLC, Piscataway, NJ 08854 USA; CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi
Top Reported Reactions
1
FATIGUE
952 reports
2
DRUG INEFFECTIVE
852 reports
3
NAUSEA
835 reports
4
DIARRHOEA
751 reports
5
PAIN
624 reports
6
DIZZINESS
613 reports
7
HEADACHE
613 reports
8
OFF LABEL USE
596 reports
9
DYSPNOEA
594 reports
10
ARTHRALGIA
519 reports